These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 778263

  • 21. Modulation of the eosinophil chemotactic factor (ECF) release from various cells and their subcellular components by phospholipids.
    König W, Kroegel C, Pfeiffer P, Tesch H.
    Int Arch Allergy Appl Immunol; 1981; 65(4):417-31. PubMed ID: 6788714
    [Abstract] [Full Text] [Related]

  • 22. Slow reacting substance (SRS) from ionophore A23187-stimulated peritoneal mast cells of the normal rat. I. Conditions of generation and initial characterization.
    Yecies LD, Wedner HJ, Johnson SM, Jakschik BA, Parker CW.
    J Immunol; 1979 May; 122(5):2083-9. PubMed ID: 87453
    [Abstract] [Full Text] [Related]

  • 23. Eosinophil chemotactic lymphokine produced by spleen cells of Schistosoma japonicum-infected mice. II. Physicochemical heterogeneity of eosinophil chemotactic lymphokines selective to bone marrow- or peritoneal exudate-eosinophils.
    Owhashi M, Nawa Y.
    Int Arch Allergy Appl Immunol; 1987 May; 83(3):290-5. PubMed ID: 3110075
    [Abstract] [Full Text] [Related]

  • 24. The release of four mediators of immediate hypersensitivity from human leukemic basophils.
    Lewis RA, Goetzl EJ, Wasserman SI, Valone FH, Rubin RH, Austen KF.
    J Immunol; 1975 Jan; 114(1 Pt 1):87-92. PubMed ID: 46247
    [Abstract] [Full Text] [Related]

  • 25. Immunologic and ionophore-induced generation of leukotriene B4 from mouse bone marrow-derived mast cells.
    Mencia-Huerta JM, Razin E, Ringel EW, Corey EJ, Hoover D, Austen KF, Lewis RA.
    J Immunol; 1983 Apr; 130(4):1885-90. PubMed ID: 6300233
    [Abstract] [Full Text] [Related]

  • 26. The regulation of tissue eosinophil chemotactic factor and inhibitor in allergic skin lesions of Freund's complete adjuvant-treated guinea-pigs.
    Hirashima M, Tashiro K, Hayashi H.
    Immunology; 1984 Mar; 51(3):441-50. PubMed ID: 6365742
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Stimulation of basophil and rat mast cell histamine release by eosinophil granule-derived cationic proteins.
    Zheutlin LM, Ackerman SJ, Gleich GJ, Thomas LL.
    J Immunol; 1984 Oct; 133(4):2180-5. PubMed ID: 6206154
    [Abstract] [Full Text] [Related]

  • 29. The mediation of tissue eosinophilia in hypersensitivity reactions. IV. Production of delayed eosinophil chemotactic factor-a by peritoneal exudate cells from sensitized guinea-pigs in vitro.
    Hirashima M, Hirotsu Y, Hayashi H.
    Immunology; 1983 Jan; 48(1):69-77. PubMed ID: 6848455
    [Abstract] [Full Text] [Related]

  • 30. The mediation of tissue eosinophilia in hypersensitivity reactions. III. Separation of two different delayed eosinophil chemotactic factors and transfer of these factors by serum or cells from sensitized guinea-pigs.
    Hirotsu Y, Hirashima M, Hayashi H.
    Immunology; 1983 Jan; 48(1):59-67. PubMed ID: 6336716
    [Abstract] [Full Text] [Related]

  • 31. Ascaris and eosinophil. II. Isolation and characterization of eosinophil chemotactic factor and neutrophil chemotactic factor of parasite in Ascaris antigen.
    Tanaka J, Baba T, Torisu M.
    J Immunol; 1979 Jan; 122(1):302-8. PubMed ID: 762419
    [Abstract] [Full Text] [Related]

  • 32. Structural requirements for the activity of an immunologically generated lipid chemotactic factor.
    Valone FH, Goetzl EJ.
    Immunology; 1980 Nov; 41(3):517-24. PubMed ID: 6780447
    [Abstract] [Full Text] [Related]

  • 33. Inactivation of polymorphonuclear-neutrophil derived eosinophil chemotactic factor by human serum.
    König W, Czarnetzki BM.
    Int Arch Allergy Appl Immunol; 1978 Nov; 57(5):399-410. PubMed ID: 352966
    [Abstract] [Full Text] [Related]

  • 34. Chemotactic responses of normal human basophils to C5a and to lymphocyte-derived chemotactic factor.
    Lett-Brown MA, Boetcher DA, Leonard EJ.
    J Immunol; 1976 Jul; 117(1):246-52. PubMed ID: 932427
    [Abstract] [Full Text] [Related]

  • 35. The formation and release of slow reacting substance of anaphylaxis (SRS-A) by rat and mouse peritoneal mononuclear cells induced by ionophore A23187.
    Orange RP, Moore EG, Gelfand EW.
    J Immunol; 1980 May; 124(5):2264-7. PubMed ID: 6767784
    [Abstract] [Full Text] [Related]

  • 36. Establishment of a human T-cell line constitutively producing several eosinophil chemotactic lymphokines and their functional heterogeneity on eosinophils.
    Hirashima M, Ueno M, Higuchi S, Matsumoto T, Sakata KM, Matsumoto R, Adachi M.
    Lymphokine Cytokine Res; 1992 Dec; 11(6):331-8. PubMed ID: 1335763
    [Abstract] [Full Text] [Related]

  • 37. Ablation of immunity to Amblyomma americanum by anti-basophil serum: cooperation between basophils and eosinophils in expression of immunity to ectoparasites (ticks) in guinea pigs.
    Brown SJ, Galli SJ, Gleich GJ, Askenase PW.
    J Immunol; 1982 Aug; 129(2):790-6. PubMed ID: 7086142
    [Abstract] [Full Text] [Related]

  • 38. Production of platelet-activating factor by stimulated human polymorphonuclear leukocytes. Correlation of synthesis with release, functional events, and leukotriene B4 metabolism.
    Sisson JH, Prescott SM, McIntyre TM, Zimmerman GA.
    J Immunol; 1987 Jun 01; 138(11):3918-26. PubMed ID: 3035016
    [Abstract] [Full Text] [Related]

  • 39. Substances which aggregate neutrophils. Mechanism of action.
    O'Flaherty JT, Showell HJ, Becker EL, Ward PA.
    Am J Pathol; 1978 Jul 01; 92(1):155-66. PubMed ID: 356621
    [Abstract] [Full Text] [Related]

  • 40. [Type IV allergic reaction (delayed type)].
    Hirashima M.
    Nihon Rinsho; 1993 Mar 01; 51(3):669-74. PubMed ID: 8492441
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.